Hendrik Struik


    ​Mr. Struik is Chief Executive Officer of LABSCO, and concurrently serves as an operating partner at Frazier Healthcare, a private equity firm that acquired LABSCO in spring 2011. Mr. Struik joined Frazier Healthcare in July 2012, working with the firm's Growth Equity team to identify opportunities in differentiated medical products, supplies and devices and outsourced technology-enabled services. Prior to his employment at LABSCO, Mr. Struik served as President, Chief Executive Officer and a director for Sarnova, a privately held $400 million Specialty Healthcare business service Acute Respiratory Market and the Emergency Medicine Market from 2009 to 2012. Mr. Struik spent over 21 years in positions of increasing scope and responsibility at Cardinal Health and predecessor companies, including Allegiance Healthcare and Baxter Healthcare, serving as President of the Respiratory and Neurocare Division of Cardinal Health. Mr. Struik’s responsibilities have included overseeing sales, manufacturing and operations and well as acquisitions, divestitures and integration of companies and business units. Mr. Struik also has substantial experience in United States and European regulatory matters. Mr. Struik holds a Masters in Business Administration, Marketing and Finance from Kellogg Business School at Northwestern University.

    © 2012-2017 MGC Diagnostics Corporation. All Rights Reserved. Privacy Policy | Terms of Use
    MGC Diagnostics and its affiliates are equal opportunity/affirmative action employers committed to cultural diversity in the workplace and complies with Executive Orders 11246 and 13496 and hereby provides notice of its compliance with FAR 52-222-26, 29 CFR Part 471, Appendix A to Subpart A, 41 C.F.R. 60-1.4, 41 C.F.R. 60-250.5, and 41 C.F.R. 60-741.5.